Patient Opportunity A (LGOAX)

Fund Assets	2.04B
Expense Ratio	1.69%
Min. Investment	$1,000
Turnover	27.00%
Dividend (ttm)	0.02
Dividend Yield	0.04%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	n/a

Previous Close	56.21
YTD Return	15.31%
1-Year Return	28.11%
5-Year Return	50.32%
52-Week Low	43.07
52-Week High	57.46
Beta (5Y)	1.95
Holdings	41
Inception Date	Feb 3, 2009

About LGOAX

Patient Opportunity Trust - Class A is a mutual fund focused on achieving long-term capital growth through a distinctive, value-oriented investment approach. Managed by an experienced team, the fund seeks out companies that are believed to be cyclically or secularly mispriced, spanning various investment styles, security types, industries, sectors, and market capitalizations. Operating with a high active share, the fund maintains a concentrated portfolio that is notably differentiated from broad market indices such as the S&P 500, offering diversification to investors with core equity holdings. The management team employs a contrarian and opportunistic strategy, aiming to maximize returns over multi-year periods through a flexible investment process. Patient Opportunity Trust – Class A has a history of navigating market cycles and maintains a relatively moderate portfolio turnover, reflecting its long-term perspective. The fund holds a mix of well-known companies as top holdings, with a focus on mid-cap stocks and a value tilt, positioning it as a complement to traditional equity portfolios in the mutual fund landscape.

• Fund Family: Patient Capital Management
• Category: Mid-Cap Value
• Performance Rating: Below Average
• Risk Rating: High
• Stock Exchange: NASDAQ
• Ticker Symbol: LGOAX
• Share Class: Class A
• Index: S&P 500 TR

Performance

LGOAX had a total return of 28.11% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.89%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIQCX	Fidelity	Fidelity Advisor Asset Manager 85% - Class Z	0.56%
FBRNX	Fidelity	Fidelity Advisor Stock Selector Fund - Class I	0.54%
FSSKX	Fidelity	Fidelity Stock Selector Fund - Class K	0.42%
FSJHX	Fidelity	Fidelity Advisor Stock Selector Fund - Class M	1.04%
FEYAX	Fidelity	Fidelity Advisor Asset Manager 85% - Class A	0.92%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MVISX	Class Is	1.33%
LMNOX	Class I	1.39%
LMOFX	Class Fi	1.74%
LMORX	Class R	1.94%

Top 10 Holdings

49.69% of assets

Name	Symbol	Weight
Royalty Pharma plc	RPRX	6.33%
Citigroup Inc.	C	6.32%
Alphabet Inc.	GOOGL	6.05%
UnitedHealth Group Incorporated	UNH	5.63%
Amazon.com, Inc.	AMZN	5.11%
NVIDIA Corporation	NVDA	4.52%
CVS Health Corporation	CVS	4.09%
QXO, Inc.	QXO	4.06%
Norwegian Cruise Line Holdings Ltd.	NCLH	3.81%
Precigen Warrant Restricted	n/a	3.80%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 27, 2024	$0.02059	Dec 27, 2024

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 19, 2026

Data Sources Report a data error